Liothyronine Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 6 USDMF, 3 CEP/COS, 1 JDMF, 4 EU WC, 1 KDMF, 7 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 28 FDA Orange Book, 6 Europe, 4 Canada, 2 Australia, 3 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE, TABLET;ORAL - EQ 0.025MG BASE, TABLET;ORAL - EQ 0.05MG BASE, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 18 SPI Pharma, 8 DKSH, 5 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Pfanstiehl, 4 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 28 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 26 Direct Compression, 24 Thickeners and Stabilizers, 20 Taste Masking, 20 Controlled & Modified Release, 19 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 15 Granulation, 13 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 9 Film Formers & Plasticizers, 9 Empty Capsules, 8 Parenteral, 4 Solubilizers, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Coloring Agents, 2 Topical